Department of Intensive Care Unit, Affiliated Hospital of Hebei University of Engineering, Handan, China.
Department of Intensive Care Unit, Affiliated Hospital of Hebei University of Engineering, Handan, China
Ann Clin Lab Sci. 2024 Jul;54(4):525-532.
Cell division cycle 42 (CDC42) modulates inflammation and multiple organ dysfunction by regulating T-cell differentiation and macrophage polarization. This research intended to explore the association of blood CDC42 expression with septic risk, multi-organ dysfunctions, and mortality.
145 sepsis patients and 50 health controls were recruited, then CDC42 expression in peripheral blood mononuclear cell (PBMC) from them was measured by RT-qPCR.
CDC42 was decreased in sepsis patients versus health controls (<0.001); meanwhile, the receiver operating characteristic (ROC) curve showed that CDC42 had a certain value to predict sepsis risk with an area under the curve (AUC) (95% confidence interval (CI): 0.797 (0.725-0.869). Furthermore, CDC42 was negatively correlated with C-reactive protein (<0.001), tumor necrosis factor-alpha (<0.001) and interleukin-17A (<0.001) but less with interleukin-6 (=0.056). Moreover, CDC42 was negatively related to the SOFA score (<0.001) and its several subscales (respiratory system, liver, cardiovascular, and renal system) (<0.05). Furthermore, CDC42 was lower in septic deaths versus survivors (<0.001); meanwhile, the ROC curve exhibited a certain ability of CDC42 in estimating 28-day mortality with an AUC (95%CI) of 0.766 (0.676-0.855).
Circulating CDC42 exhibits potency to be a prognostic biomarker reflecting multi-organ dysfunctions and higher mortality risk in sepsis.
细胞分裂周期蛋白 42(CDC42)通过调节 T 细胞分化和巨噬细胞极化来调节炎症和多器官功能障碍。本研究旨在探讨外周血 CDC42 表达与脓毒症风险、多器官功能障碍和死亡率的关系。
招募了 145 例脓毒症患者和 50 例健康对照者,然后通过 RT-qPCR 测量他们外周血单个核细胞(PBMC)中的 CDC42 表达。
与健康对照者相比,脓毒症患者的 CDC42 降低(<0.001);同时,受试者工作特征(ROC)曲线表明,CDC42 对预测脓毒症风险具有一定价值,曲线下面积(AUC)(95%置信区间(CI):0.797(0.725-0.869)。此外,CDC42 与 C 反应蛋白(<0.001)、肿瘤坏死因子-α(<0.001)和白细胞介素-17A(<0.001)呈负相关,但与白细胞介素-6 呈负相关(=0.056)。此外,CDC42 与 SOFA 评分(<0.001)及其几个亚量表(呼吸系统、肝脏、心血管和肾脏系统)(<0.05)呈负相关。此外,死亡患者的 CDC42 明显低于存活患者(<0.001);同时,ROC 曲线显示 CDC42 在评估 28 天死亡率方面具有一定的能力,AUC(95%CI)为 0.766(0.676-0.855)。
循环中的 CDC42 具有作为反映脓毒症多器官功能障碍和更高死亡率风险的预后生物标志物的潜力。